0001209191-21-002566.txt : 20210107
0001209191-21-002566.hdr.sgml : 20210107
20210107175833
ACCESSION NUMBER: 0001209191-21-002566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210105
FILED AS OF DATE: 20210107
DATE AS OF CHANGE: 20210107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KELLEY SCOTT
CENTRAL INDEX KEY: 0001222950
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36287
FILM NUMBER: 21515067
MAIL ADDRESS:
STREET 1: C/O ASPECT MEDICAL SYSTEMS INC
STREET 2: 141 NEEDHAM ST
CITY: NEWTON
STATE: MA
ZIP: 02464-1505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Flexion Therapeutics Inc
CENTRAL INDEX KEY: 0001419600
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: (781) 305-7777
MAIL ADDRESS:
STREET 1: 10 MALL ROAD
STREET 2: SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-05
0
0001419600
Flexion Therapeutics Inc
FLXN
0001222950
KELLEY SCOTT
C/O FLEXION THERAPEUTICS, INC.
10 MALL ROAD, SUITE 301
BURLINGTON
MA
01803
0
1
0
0
Chief Medical Officer
Common Stock
2021-01-05
4
S
0
6829
11.13
D
113549
D
Sale of shares of common stock to cover tax withholding obligations associated with the vesting of restricted stock unit awards granted to the Reporting Person on February 1, 2018, March 1, 2019, and March 2, 2020.
The weighted average sale price for the transaction reported was $11.13. The shares were sold at a range of prices between $11.12 and $11.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Includes 668 shares of Common Stock that were acquired by the Reporting Person on December 21, 2020, at $9.77 per share pursuant to the Issuer's Employee Stock Purchase Plan.
/s/ Mark S. Levine, Attorney-in-Fact
2021-01-07